Clinical trial

Safety and Efficacy Study of M2951 in Participants With Rheumatoid Arthritis

NCT02784106

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention M2951 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Efficacy Study of M2951 in Participants With Rheumatoid Arthritis

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-07-31

PhasePHASE2

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

PlaceboDRUG

M2951DRUG

Sponsors & collaborators

EMD Serono Research & Development Institute, Inc.lead sponsor

Merck KGaA, Darmstadt, Germanycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02784106 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.